Publications

Tolaney SM, Sonpavde GP, Tarantino P, Lustberg MB, Rugo HS. Clinical perspective on management of key adverse events with sacituzumab govitecan. The oncologist. 2025. PMID: 41006069

Jiang CY, Hwang H, Epstein IY, Bakaloudi DR, Talukder R, Taylor AK, Nizam A, Jindal T, Glover MJ, Khaki AR, Barata PC, Nguyen CB, Oh E, Davis NB, Mabey H, Hoimes CJ, Evans ST, Abuqayas B, Lemke E, Tsung I, Qiao W, Kilari D, Zakharia Y, Bilen MA, Milowsky MI, Shah SA, Gupta S, Emamekhoo H, Bellmunt J, Alva AS, Grivas P, Msaouel P, Koshkin VS, Campbell MT, Alhalabi O. Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study. The oncologist. 2025. PMID: 41056445

Panian J, Henderson NC, Herchenhorn D, Barata PC, Bilen MA, Graham L, Heath E, Hwang C, Supernois A, Kilari D, Thapa B, Koshkin VS, Jindal T, Nauseef JT, Sokolova A, Amery T, Zakharia Y, Schweizer MT, Raychaudhuri R, Reichert ZR, Dorff T, Armstrong AJ, Wang J, Alva A, McKay RR. Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617. The oncologist. 2025. PMID: 41124032

Li Y, Qiu X, Sandusky Z, Tagliaferri K, Li R, Yang X, Zhang T, Liu S, Yan P, Lu F, Jones M, Xiao T, Li W, Goldman S, Cui J, Polyak K, Liu XS, Long HW, Gregory RI, Adelman K, Rosenbluth JM, Brown M. METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformation. Proceedings of the National Academy of Sciences of the United States of America. 2025. PMID: 41218124

Abrams RPM, Donahue RG, Ma J, Mao Y, Diolaiti ME, Ashworth A. An engineered cysteine sensor optimized for high-throughput screening identifies regulators of intracellular thiol levels. Cell chemical biology. 2025. PMID: 41218609

Llanes KD, Vijayaraghavan M, Schneider S, Ling PM, Hernandez E, Brunetta P, Song AV, Durazo A. Digital Smoking Cessation Preferences of Predominately Low-Income and Latino Residents of the San Joaquin Valley in California: Qualitative Study. JMIR formative research. 2025. PMID: 41213091

Gujar R, Cui C, Fumagalli M, Martinez N, Bahador A, Algazi A, Harrington K, Turner C, Becker L. Developing a therapeutic elastase that stimulates anti-tumor immunity by selectively killing cancer cells. Cell reports. Medicine. 2025. PMID: 41205593

Smabers LP, Nienhuis HH, de Leng WWJ, Roepman P, Ciftcibasi IÖA, Wensink GE, Huismans MA, Valkenburg-van Iersel LBJ, Cirkel GA, Gootjes EC, Verheul HMW, Jeurissen FJ, Bol GM, Kranenburg O, Koopman M, Cuppen E, Roodhart JML. Clinical implications of whole genome sequencing in metastatic colorectal cancer. Oncogene. 2025. PMID: 41203868

Zwart K, van Kruijsdijk RCM, Angerilli V, Baas MC, Dekker E, Rutgers N, May A, Koopman M, Nagtegaal ID, Bol GM. Risk of deficient mismatch repair colorectal cancer and precursors after kidney transplantation: A nationwide study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2025. PMID: 41207478

Hoff FW, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike O, Zeidner JF, Olin RL, Smith CC, Schiller GJ, Curran EK, Handa SV, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Byrd JC, Madanat YF. IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy. Haematologica. 2025. PMID: 41195510

Singal AG, Garcia-Reyes K, Kelley RK, Kim E. Impact of LEAP-012 and EMERALD-1 in the management of HCC. JHEP reports : innovation in hepatology. 2025. PMID: 41503570

Li H, Melnyk JE, Fu BXH, Shrestha R, Zhang M, Sjöström M, Feng S, Anderson JA, Han W, Chesner LN, Shin HJ, Farsh T, Suarez HJ, Nath S, Chou J, Das R, Egusa EA, Calvert M, Kishishita A, Barpanda A, Zhu J, Maheshwari A, Chen WS, Alshalalfa M, Winters A, Hua JT, Liu T, Davicioni E, Wiita AP, Stohr BA, Siddiqui J, Huang B, Small EJ, Shokat KM, Nelson PS, Quigley DA, Wasmuth EV, Gilbert LA, Feng FY. Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer. Nature genetics. 2025. PMID: 41193657

Ho C, Kennedy N, Di M, Gopal AK, Lynch RC, Ng K, Wu QV, Poh C, Raghunathan V, Rasmussen H, Shadman M, Till BG, Ujjani CS, Smith SD. Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma. Clinical lymphoma, myeloma & leukemia. 2025. PMID: 41285650

Chen WS, Tuchayi AM, Sabbagh A, Kim I, Porter E, Ashraf-Ganjouei A, Li YR, Witztum A, Rajagopal A, Seyedin SN, Juarez R, Carroll PR, Feng FY, Small EJ, Hope TA, Hong JC. Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer. JNCI cancer spectrum. 2025. PMID: 41063390

Khartchenko AF, Lam T, Goldhammer N, Bont M, Warhadpande S, Rosenbluth JM, Herr AE. EpiBlot: Joint Mapping of Chromatin Accessibility and Targeted Proteomics in HER2-expressing Breast Cancer Systems. bioRxiv : the preprint server for biology. 2025. PMID: 41040387

de Mestier L, Halfdanarson TR, Apostolidis L, Koumarianou A, Hernando J, Riechelmann R, Bergsland EK, Cingarlini S, Shaheen S, Crona J, Kreutzfeldt S, Mosalem O, Al-Toubah T, Cros J, Strosberg JR. Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy. Endocrine pathology. 2025. PMID: 41182464

Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Bailey J, Burstein HJ, Chen N, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, McCloskey S, McShane M, Mortimer J, Patel SA, Rosenberger LH, Rugo HS, Santa-Maria CA, Schneider BP, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Yellala A, Yeung KT, Young JS, Schonfeld R, Kumar R. NCCN Guidelines® Insights: Breast Cancer, Version 5.2025. Journal of the National Comprehensive Cancer Network : JNCCN. 2025. PMID: 41213254

Ye J, Goldhammer N, Vohra P, Warhadpande S, de Castro GC, Rodas CKM, Moasser MM, Ramalingam K, Abe SE, Alvarado M, Ewing C, Goodwin KM, Mukhtar RA, Wong JM, Esserman LJ, Balassanian R, Rosenbluth JM. FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ. Cancer cytopathology. 2025. PMID: 41066221

Greenland NY, Cowan JE, Ding CC, Sirohi D, Cooperberg MR, Carroll PR, Simko JP, Stohr BA, Zhang L, Chan E. Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence. Histopathology. 2025. PMID: 41171098

Frazer K, Vijayaraghavan M. Syndemic lives of women who smoke and experience homelessness: secondary analysis of US qualitative data. Health promotion international. 2025. PMID: 41433202